Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Xidelong Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company headquartered in the High-tech Development Zone of Xi'an, Shaanxi Province. Established in 2004, the company specializes in the research, development, and large-scale manufacturing of chemical drugs and active pharmaceutical ingredients (APIs). Its most prominent product is Sildenafil Citrate, which is marketed under the brand name Xidelong for the treatment of erectile dysfunction. The company operates modern, GMP-certified production facilities and maintains a strong presence in the domestic Chinese market for men's health products. Beyond its flagship urology portfolio, the firm is involved in the production of various generic chemical medications and chemical raw materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xidelong Pharmaceutical.